The development and adoption of non-animal research methods represents one of the most significant opportunities to reduce animal suffering in scientific research.
Millions of animals suffer annually in research that is often poorly predictive of human biology. New organ-on-chip, organoid, and computer modeling technologies increasingly outperform animal models for human drug safety and efficacy testing. Regulatory reform enabling these alternatives is advancing, but institutional inertia and funding structures still incentivize animal use.